Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Western Uranium & Vanadium (WSTRF) EBITDA (2016 - 2025)

Historic EBITDA for Western Uranium & Vanadium (WSTRF) over the last 8 years, with Q3 2025 value amounting to -$1.1 million.

  • Western Uranium & Vanadium's EBITDA rose 4920.27% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.5 million, marking a year-over-year increase of 614.51%. This contributed to the annual value of -$10.3 million for FY2024, which is 11600.17% down from last year.
  • Western Uranium & Vanadium's EBITDA amounted to -$1.1 million in Q3 2025, which was up 4920.27% from -$2.0 million recorded in Q2 2025.
  • Over the past 5 years, Western Uranium & Vanadium's EBITDA peaked at $2.1 million during Q2 2022, and registered a low of -$2.7 million during Q4 2024.
  • Over the past 5 years, Western Uranium & Vanadium's median EBITDA value was -$1.1 million (recorded in 2022), while the average stood at -$1.3 million.
  • Data for Western Uranium & Vanadium's EBITDA shows a peak YoY increase of 55782.82% (in 2022) and a maximum YoY decrease of 35284.49% (in 2022) over the last 5 years.
  • Western Uranium & Vanadium's EBITDA (Quarter) stood at -$411831.0 in 2021, then plummeted by 216.71% to -$1.3 million in 2022, then decreased by 17.3% to -$1.5 million in 2023, then crashed by 78.92% to -$2.7 million in 2024, then skyrocketed by 58.67% to -$1.1 million in 2025.
  • Its EBITDA stands at -$1.1 million for Q3 2025, versus -$2.0 million for Q2 2025 and -$2.7 million for Q1 2025.